These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8892678

  • 1. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts.
    Lee YY, Kim ES, Seol JG, Kim BK, Binderup L, Elstner E, Park DJ, Koeffler HP.
    Leukemia; 1996 Nov; 10(11):1751-7. PubMed ID: 8892678
    [Abstract] [Full Text] [Related]

  • 2. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
    Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca HF.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
    [Abstract] [Full Text] [Related]

  • 3. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R, Grünebach F, Bader P, Vogel W, Kanz L, Brugger W, Scheding S.
    J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
    [Abstract] [Full Text] [Related]

  • 4. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Dec; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.
    Munker R, Norman A, Koeffler HP.
    J Clin Invest; 1986 Aug; 78(2):424-30. PubMed ID: 3461004
    [Abstract] [Full Text] [Related]

  • 6. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 7. Effect of a novel vitamin D3 analog, EB1089, on G1 cell cycle regulatory proteins in HL-60 cells.
    Seol JG, Park WH, Kim ES, Jung CW, Binderup L, Koeffler HP, Kim BK, Lee YY.
    Int J Oncol; 2000 Feb 01; 16(2):315-20. PubMed ID: 10639575
    [Abstract] [Full Text] [Related]

  • 8. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH, Talpaz M, Deisseroth AB, Estrov Z.
    Leukemia; 1996 May 01; 10(5):757-65. PubMed ID: 8656668
    [Abstract] [Full Text] [Related]

  • 9. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP.
    Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602
    [Abstract] [Full Text] [Related]

  • 10. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP, Hirji K, Itri L.
    Cancer Treat Rep; 1985 Dec 15; 69(12):1399-407. PubMed ID: 2416438
    [Abstract] [Full Text] [Related]

  • 11. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.
    Exp Hematol; 1995 Dec 15; 23(14):1439-44. PubMed ID: 8542929
    [Abstract] [Full Text] [Related]

  • 12. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 15; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 13. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

  • 14. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS, Kim JY, Park HK, Kim ES, Ahn KS, Yoon SS, Cho CG, Kim BK, Lee YY.
    Int J Oncol; 2008 Feb 01; 32(2):387-96. PubMed ID: 18202761
    [Abstract] [Full Text] [Related]

  • 15. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV, Bai W.
    Clin Cancer Res; 2005 Jan 01; 11(1):323-8. PubMed ID: 15671562
    [Abstract] [Full Text] [Related]

  • 16. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
    Elstner E, Lee YY, Hashiya M, Pakkala S, Binderup L, Norman AW, Okamura WH, Koeffler HP.
    Blood; 1994 Sep 15; 84(6):1960-7. PubMed ID: 8080998
    [Abstract] [Full Text] [Related]

  • 17. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 18. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C, Mangoni L, Almici C, Frassoni F, Fiers W, Rizzoli V.
    Leukemia; 1990 Aug 15; 4(8):561-6. PubMed ID: 1697011
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia.
    Yu J, Papavasiliou V, Rhim J, Goltzman D, Kremer R.
    Anticancer Drugs; 1995 Feb 15; 6(1):101-8. PubMed ID: 7756673
    [Abstract] [Full Text] [Related]

  • 20. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells].
    He Q, Xu YH.
    Yao Xue Xue Bao; 1996 Feb 15; 31(5):340-5. PubMed ID: 9275711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.